Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 215194
Company: SPECGX LLC
Company: SPECGX LLC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
MORPHINE SULFATE | MORPHINE SULFATE | 15MG | TABLET;ORAL | Prescription | AB | No | No |
MORPHINE SULFATE | MORPHINE SULFATE | 30MG | TABLET;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/21/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
MORPHINE SULFATE
TABLET;ORAL; 15MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
MORPHINE SULFATE | MORPHINE SULFATE | 15MG | TABLET;ORAL | Prescription | No | AB | 212451 | ALKEM LABS LTD |
MORPHINE SULFATE | MORPHINE SULFATE | 15MG | TABLET;ORAL | Prescription | Yes | AB | 022207 | HIKMA |
MORPHINE SULFATE | MORPHINE SULFATE | 15MG | TABLET;ORAL | Prescription | No | AB | 215194 | SPECGX LLC |
MORPHINE SULFATE | MORPHINE SULFATE | 15MG | TABLET;ORAL | Prescription | No | AB | 210610 | UPSHER SMITH LABS |
TABLET;ORAL; 30MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
MORPHINE SULFATE | MORPHINE SULFATE | 30MG | TABLET;ORAL | Prescription | No | AB | 212451 | ALKEM LABS LTD |
MORPHINE SULFATE | MORPHINE SULFATE | 30MG | TABLET;ORAL | Prescription | Yes | AB | 022207 | HIKMA |
MORPHINE SULFATE | MORPHINE SULFATE | 30MG | TABLET;ORAL | Prescription | No | AB | 215194 | SPECGX LLC |
MORPHINE SULFATE | MORPHINE SULFATE | 30MG | TABLET;ORAL | Prescription | No | AB | 210610 | UPSHER SMITH LABS |